Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05721261 · ClinicalTrials.gov registry record · NA
Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation
A NA study of Nerve Injury, sponsored by Epineuron Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 15
- Study locations
NCT05721261: Recruiting NA study of Nerve Injury, sponsored by Epineuron Technologies.
NCT05721261 is a NA study of Nerve Injury that is actively recruiting participants, run by Epineuron Technologies. The registered enrollment target is 110 participants, above the 57-participant average among 7 other Nerve Injury trials with a reported enrollment target (93% higher). The trial reports 15 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05721261, a NA study of Nerve Injury, is actively recruiting participants, sponsored by Epineuron Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 15
- Study locations
Study Summary
A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.
Conditions Studied
Interventions
- DEVICE Temporary Peripheral Nerve Stimulation System
- DEVICE Sham Temporary Peripheral Nerve Stimulation System
Study Locations (15)
Ontario
- Hamilton General Hospital - Hamilton
- St. Joseph's Healthcare Hamilton - Hamilton
- Roth | McFarlane Hand & Upper Limb Centre - London
- Southlake Health - Newmarket
- Humber River Health - Toronto
- North York General Hospital - Toronto
- Trillium Health Partners - Toronto
Florida
- University of Florida Health - Gainesville
- Orlando Health Jewett Orthopedic Institute - Orlando
Louisiana
- Louisiana State University Health Sciences Center - New Orleans
Maryland
- The Curtis National Hand Center - Baltimore
Pennsylvania
- WellSpan Health - York
Texas
- John Peter Smith Hospital - Fort Worth
Alberta
- University of Alberta Hospital - Edmonton
New Brunswick
- Saint John Regional Hospital - Saint John
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-08-11 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT05721261 shows while recruiting
NCT05721261 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, above the 57-participant average among 7 other Nerve Injury trials with a reported enrollment target (93% higher).
The record links to 1 condition, with Nerve Injury appearing as the primary indexed condition, and to 2 interventions - of which Temporary Peripheral Nerve Stimulation System is the first listed.
NCT05721261 lists 15 locations in 8 states (Ontario, Florida, Louisiana).
Frequently Asked Questions
What is clinical trial NCT05721261 about?
NCT05721261 is a clinical study titled "Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation". A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.
What is the current status of trial NCT05721261?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2023-08-11. Estimated completion is 2026-09.
What conditions does trial NCT05721261 study?
This clinical trial studies the following conditions: Nerve Injury.
What interventions are being tested in trial NCT05721261?
The interventions under investigation include: Temporary Peripheral Nerve Stimulation System (DEVICE), Sham Temporary Peripheral Nerve Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT05721261?
This trial is sponsored by Epineuron Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05721261 being conducted?
This trial has 15 study locations across Florida, Louisiana, Maryland, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nerve Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
RECRUITING · NA
-
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
RECRUITING · NA
-
Evaluating Therapeutic Electrical Stimulation to Improve Nerve Healing After Surgical Repair of Digital Nerve Injuries
RECRUITING · NA
-
Promoting Healing of Nerves Through Electrical Stimulation
ACTIVE NOT RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI